Emergency Medicine clinicians, Primary Care clinicians, Gastroenterologists
Acute hepatic porphyria, porphyria
Herbert L. Bonkovsky, MD
Professor of Medicine and Molecular Medicine and Translational Science
Director of Laboratory for Liver & Metabolic Disorders
Wake Forest University School of Medicine/NC Baptist Hospital
Winston-Salem, North Carolina
Herbert L. Bonkovsky, MD, is a tenured Professor of Medicine and Molecular Medicine & Translational Research and Director of Hepatology/Liver Service Line and The Liver and Metabolic Disorders Laboratory at Wake Forest University/NC Baptist Medical Center, Winston-Salem, NC. Dr. Bonkovsky also has academic appointments as Visiting Professor at Winston-Salem State University, Professor of Medicine at The University of CT Health Center, and Professor of Biology and Medicine at the University of North Carolina.
Dr. Bonkovsky is known nationally and internationally as a clinical hepatologist, teacher, mentor, and clinical investigator. Dr. Bonkovsky has continued to maintain an active clinical practice, focused on liver disorders and metabolic disorders, especially disorders of iron, porphyrin, and heme metabolism. His currently funded research is in porphyrin and heme metabolism, effects of heme and iron on gene expression and intermediary metabolism, and drug- and herbal supplement-induced liver injury.
Information on this Educational Activity
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Herbert L. Bonkovsky, MD, has disclosed that he received consulting fees from Recordati Rare Chemicals and funds for research support from Alnylam, Gilead Sciences, and Mitsubishi Tanabe.
Zachary Schwartz, MSc, ELS
Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Anne Roc, PhD
Director, Scientific Services
Anne Roc, PhD, has no relevant conflicts of interest to report.
Wendy Gloffke, PhD
Wendy Gloffke, PhD, has no relevant conflicts of interest to report.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is primarily intended for gastroenterologists, emergency medicine specialists, primary care practitioners and other clinicians who may see patients with abdominal symptoms related to porphyria.
The goal of this activity is to improve the competence of learners in considering rare causes of acute abdominal pain and to perform appropriate diagnostic tests in a timely manner to establish the correct diagnosis.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
COURSE VIEWING REQUIREMENTS